down arrow

Godavari Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE362C01012
  • NSEID:
  • BSEID: 530317
INR
93.00
1.7 (1.86%)
BSENSE

Apr 11, 12:42 PM

BSE+NSE Vol: 388

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

93.0098.00

52 Week

79.00155.00
Valuation
Technical
Day's Volume

CASH

388 (-64.23%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.50%

Held by 0 DIIs

Promoter

52.63%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a 16.62% CAGR growth in Operating Profits over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.15 times
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 74 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.34

stock-summary
Return on Equity

14.82%

stock-summary
Price to Book

1.65

Revenue and Profits (1 Year):
Net Sales:
30 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-25.54%
0%
-25.54%
1 Year
-6.63%
0%
-6.63%
2 Years
19.74%
0%
19.74%
3 Years
30.34%
0%
30.34%
4 Years
77.99%
0%
77.99%
5 Years
478.0%
0%
478.0%

Godavari Drugs for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.69%
EBIT Growth (5y)
16.62%
EBIT to Interest (avg)
2.38
Debt to EBITDA (avg)
3.51
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.20
Tax Ratio
11.76%
Dividend Payout Ratio
0
Pledged Shares
0.25%
Institutional Holding
0.50%
ROCE (avg)
13.60%
ROE (avg)
14.95%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
33
Price to Book Value
1.65
EV to EBIT
11.46
EV to EBITDA
9.46
EV to Capital Employed
1.28
EV to Sales
0.99
PEG Ratio
0.21
Dividend Yield
NA
ROCE (Latest)
12.26%
ROE (Latest)
14.82%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

0.2523

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sushma Kakani (15.34%)

Highest Public shareholder

Highcrestt Global Company Ltd (2.66%)

Individual Investors Holdings

39.98%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 13.26% vs -19.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -29.36% vs -33.13% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.55",
          "val2": "26.09",
          "chgp": "13.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.57",
          "val2": "2.90",
          "chgp": "-11.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.11",
          "val2": "1.08",
          "chgp": "2.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.77",
          "val2": "1.09",
          "chgp": "-29.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.70%",
          "val2": "11.12%",
          "chgp": "-2.42%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -22.23% vs -9.80% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 62.87% vs -6.70% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "58.30",
          "val2": "74.96",
          "chgp": "-22.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.14",
          "val2": "5.31",
          "chgp": "15.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.52",
          "val2": "2.41",
          "chgp": "4.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.72",
          "val2": "1.67",
          "chgp": "62.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.53%",
          "val2": "7.08%",
          "chgp": "3.45%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -25.59% vs -3.43% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 20.76% vs 17.48% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "87.85",
          "val2": "118.07",
          "chgp": "-25.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.71",
          "val2": "8.83",
          "chgp": "-1.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.63",
          "val2": "3.68",
          "chgp": "-1.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.06",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.49",
          "val2": "2.89",
          "chgp": "20.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.91%",
          "val2": "7.48%",
          "chgp": "2.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -1.82% vs -0.92% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 46.44% vs -27.81% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "156.71",
          "val2": "159.62",
          "chgp": "-1.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "9.91",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.92",
          "val2": "3.93",
          "chgp": "25.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.09",
          "val2": "0.23",
          "chgp": "-139.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.55",
          "val2": "3.79",
          "chgp": "46.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "6.21%",
          "chgp": "-6.21%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
29.55
26.09
13.26%
Operating Profit (PBDIT) excl Other Income
2.57
2.90
-11.38%
Interest
1.11
1.08
2.78%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.77
1.09
-29.36%
Operating Profit Margin (Excl OI)
8.70%
11.12%
-2.42%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 13.26% vs -19.00% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -29.36% vs -33.13% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
58.30
74.96
-22.23%
Operating Profit (PBDIT) excl Other Income
6.14
5.31
15.63%
Interest
2.52
2.41
4.56%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.72
1.67
62.87%
Operating Profit Margin (Excl OI)
10.53%
7.08%
3.45%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -22.23% vs -9.80% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 62.87% vs -6.70% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
87.85
118.07
-25.59%
Operating Profit (PBDIT) excl Other Income
8.71
8.83
-1.36%
Interest
3.63
3.68
-1.36%
Exceptional Items
0.00
-0.06
100.00%
Standalone Net Profit
3.49
2.89
20.76%
Operating Profit Margin (Excl OI)
9.91%
7.48%
2.43%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -25.59% vs -3.43% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 20.76% vs 17.48% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
156.71
159.62
-1.82%
Operating Profit (PBDIT) excl Other Income
0.00
9.91
-100.00%
Interest
4.92
3.93
25.19%
Exceptional Items
-0.09
0.23
-139.13%
Standalone Net Profit
5.55
3.79
46.44%
Operating Profit Margin (Excl OI)
0.00%
6.21%
-6.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -1.82% vs -0.92% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 46.44% vs -27.81% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Godavari Drugs Ltd stock-summary
stock-summary
Godavari Drugs Ltd
Micro Cap
Pharmaceuticals & Drugs
Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.
Company Coordinates stock-summary
Company Details
Mayfair 1-8-303-34, Sardar Patel Road Secunderabad Andhra Pradesh : 500003
stock-summary
Tel: 91-40-27849700/27844557
stock-summary
http://www.godavaridrugs.com
stock-summary
info@godavaridrugs.com
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."